ARS Pharmaceuticals, Inc. - 8-K Filing

ARS Pharmaceuticals' Richard Lowenthal resigns from board and Sarina Tanimoto leaves as CMO; both receive additional severance payments (Items: 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Offi)

SEC EDGAR ·

Tickers: $SPRY

Read the full article at SEC EDGAR

More Regulatory news